Little agreement emerged from an informal World Trade Organization (WTO) meeting on Tuesday about whether an intellectual property (IP) waiver should be extended to COVID-19 therapeutics and diagnostics. But low and middle-income countries (LMIC) that qualify for free COVID-19 anti-virals Paxlovid (nirmatrelvir) and Molnupiravir have shown so little interest in accepting donations that some question […] Continue reading ->
Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading ->
Deadlock may once again be the name of the game at the World Trade Organization’s (WTO’s) Council for Trade-Related Aspects of Intellectual Property Rights—TRIPS, for short. A communication from Switzerland and Mexico questioning the need to extend the waiver on intellectual property rights on COVID-19 vaccines to therapeutics and diagnostics is laying bare the divergences […] Continue reading ->
A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading ->
Under the leadership of Dr Bernard Pécoul, the Drugs for Neglected Diseases Initiative became one of the flagship programmes for research and development into diseases affecting the world’s most forgotten people. He has contributed to the betterment of the lives of millions, yet few outside global health circles know his name. This is his story.  […] Continue reading ->
At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading ->
To mark World Mosquito Day, 20 August, the Global Health Priority Box has been launched to provide free access to 240 compounds to stimulate research into new drugs and insecticides.  The initiative, launched by the Medicines for Malaria Venture (MMV) and the Innovative Vector Control Consortium (IVCC), provides scientists with starting points to advance the […] Continue reading ->
Overcoming years of stalemate, the World Intellectual Property Organization (WIPO) agreed to negotiate a proposed treaty on genetic resources and related traditional knowledge (TK) that are key components in both traditional and new medicines. Delegates to WIPO’s General Assembly decided that the negotiations both to begin the draft international instrument and to conclude the talks […] Continue reading ->
Major pharmaceutical companies have offered to reserve a “real-time allocation” of vaccines and treatments upfront for “priority populations in lower-income countries” in future pandemics – providing the G7 and G20 also help low-income countries finance and make effective use of the products. Launching its Berlin Declaration on Tuesday, the International Federation of Pharmaceutical Manufacturers and […] Continue reading ->
Citizens and NGOs welcomed the United Nations Human Rights Council’s adoption of a much-debated draft resolution that calls on nations to ensure everyone has access to medicines and vaccines. The resolution was adopted by consensus Friday shortly before the close of the HRC’s 50th session, sending what proponents called a “clear message” that access to […] Continue reading ->